ACHE and Alzheimer disease: Since AD is a multifactorial disease35, researchers have turned their attention to developing multi-target drugs to inhibit the myriad factors involved in AD, including protein misfolding and associated Aβ aggregation, t aggregation, metal dyshomeostasis, oxidative stress and a decrease in AChE levels.